Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
Business Insider
20h
Citi Keeps Their Buy Rating on Royalty Pharma (RPRX)
Royalty Pharma has an analyst consensus of Strong Buy, with a price target consensus of $48.00, representing an 83.14% upside. In a report released on November 7, Morgan Stanley also maintained a Buy ...
Hosted on MSN
14h
30 Most Expensive Colleges In 2024
The sticker price of some of these colleges is extreme ... namely the fact that it produces tons of STEM Ph.D. graduates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Trump sweeps swing states
FBI thwarts Iranian plot
Resigns after election losses
Newsom fined $13,000
US tourist killed in Hungary
To end debit card program
Gabriel breaks NCAA record
Ex-Blazers broadcaster dies
Wins Nevada Senate race
NASCAR legend Allison dies
Man charged with arson
Philippines new maritime laws
IL weapons ban blocked
Medical worker gets 2 years
Consumer sentiment rises
Launches bid to chair NRSC
Notre Dame bells ring again
Global food prices rise
Asked to be US trade chief
Seattle stabbing spree ends
‘Candyman' star dies
Leads Grammy nominations
Rockefeller tree arrives
Suit over Philly ballots
S&P 500 breaks 6,000 level
Gauff wins WTA Finals
Gaza crossing to reopen?
Pentagon on 9/11 defendants
US energy revenue 2024
NC highway shootings arrest
Hits $1 trillion market cap
Feedback